Design Therapeutics, Inc.

DSGN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.8B · 54 employees
62
SEC Filings
$10.44
Close 2026-06-01
54
Employees

Business Summary

7 Item 1A. Risk Factors 54 Item 1B. Unresolved Staff Comments 114 Item 1C. Cybersecurity 114 Item 2. Properties 115 Item 3. Legal Proceedings 116 Item 4. Mine Safety Disclosures 116 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 117 Item 6. [Reserved] 117 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 118 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...

Latest Stock Quote

DSGN 2026-06-01 $10.44 O:$10.41 H:$10.775 L:$10.11 Vol:1.5M VWAP:$10.5181
origin leaf: 5511552a2cf28a30b36ee34b74db6584e5075ac5f79659da06d8fae6968fa476

Next Earnings

Q2 FY2026 — expected 2026-09-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-098491EDGAR96K words
2025-03-102024-12-310000950170-25-035910EDGAR
2024-03-192023-12-310000950170-24-033492EDGAR
2023-03-142022-12-310000950170-23-007869EDGAR
2022-03-102021-12-310000950170-22-003369EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266970EDGAR65K words
2025-08-072025-06-300000950170-25-105062EDGAR
2025-05-072025-03-310000950170-25-065643EDGAR
2024-11-072024-09-300000950170-24-123349EDGAR
2024-08-052024-06-300000950170-24-090337EDGAR
2024-05-082024-03-310000950170-24-055788EDGAR
2023-11-132023-09-300000950170-23-062958EDGAR
2023-08-142023-06-300000950170-23-042411EDGAR
2023-05-092023-03-310000950170-23-019714EDGAR
2022-11-032022-09-300000950170-22-021885EDGAR
2022-08-082022-06-300000950170-22-015533EDGAR
2022-05-092022-03-310000950170-22-008500EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001193125-26-137861EDGAR1K words
2026-03-090001193125-26-098474EDGAR
2026-01-300001193125-26-031772EDGAR
2025-11-050001193125-25-266933EDGAR
2025-09-100001807120-25-000004EDGAR
2025-08-070000950170-25-105008EDGAR
2025-06-120000950170-25-085380EDGAR
2025-05-070000950170-25-065613EDGAR
2025-03-100000950170-25-035909EDGAR
2025-01-130000950170-25-004612EDGAR

62 total filings indexed. 35 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001807120
TickerDSGN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.designtx.com
Listed2021-03-26

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 51b95020fd064e51bebe51b03f9eb39b28f6e58a2b9b2be65ba7fb36d0c60795
parent: fcdead956632e576008614c3c870c6ab39a66ff466c724a0b8d4590a11dcff30
content hash: c14e685c4c67b021a5410c42aa16557eb13c3aee2f491c3524328e90d1ab1a6e
signed: 2026-06-03T12:00:53.301Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf